Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
Abstract:
The invention relates to a compound of formula (I) with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, multiple myeloma, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.
Information query
Patent Agency Ranking
0/0